Cargando…
ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca(2+)/PI3-kinase/AKT signaling pathway
Chemotherapy is the main treatment method of patients with advanced liver cancer. However, drug resistance is a serious problem in the treatment of hepatocellular carcinoma (HCC). Acid sensing ion channel 1a (ASIC1a) is a H(+)-gated cation channel; it mediates tumor cell migration and invasion, whic...
Autores principales: | Zhang, Yihao, Zhang, Ting, Wu, Chao, Xia, Quan, Xu, Dujuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220138/ https://www.ncbi.nlm.nih.gov/pubmed/27918554 http://dx.doi.org/10.1038/labinvest.2016.127 |
Ejemplares similares
-
ASIC1a induces synovial inflammation via the Ca(2+)/NFATc3/ RANTES pathway
por: Zhang, Yihao, et al.
Publicado: (2020) -
LLGL2 Increases Ca(2+) Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma
por: Leng, Shusheng, et al.
Publicado: (2021) -
Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022) -
SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
por: Yang, Yu-Feng, et al.
Publicado: (2018) -
ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway
por: Zhang, Yinci, et al.
Publicado: (2022)